Optimi Health is trading at $4.93 (up 5.1%), continuing a rally that began during thin-liquidity after-hours and pre-market sessions on July 30.

  • The upward move appears driven by improving risk appetite and broader market strength rather than fresh company-specific news or fundamental catalysts.
  • The stock is notably outperforming the broader biotech sector, which is currently trading lower.
  • Current gains extend momentum from prior sentiment-driven activity earlier in the week.